These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9160770)

  • 1. Calcium channel blockers for hypertension: dissecting the evidence for adverse effects.
    Opie LH
    Am J Hypertens; 1997 May; 10(5 Pt 1):565-77. PubMed ID: 9160770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies.
    Opie LH; Yusuf S; Kübler W
    Prog Cardiovasc Dis; 2000; 43(2):171-96. PubMed ID: 11014332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
    Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
    Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
    Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB
    J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual calcium-channel blocker therapy in the treatment of hypertension.
    Saseen JJ; Carter BL
    Ann Pharmacother; 1996; 30(7-8):802-10. PubMed ID: 8826565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differential therapy with calcium antagonists].
    Scholze JE
    Herz; 2003 Dec; 28(8):754-63. PubMed ID: 14689111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What, if anything, is controversial about calcium antagonists?
    Messerli FH
    Am J Hypertens; 1996 Dec; 9(12 Pt 2):177S-181S. PubMed ID: 8968430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of calcium antagonists: dissecting the evidence.
    Messerli FH
    Am J Cardiol; 1996 Nov; 78(9A):19-23. PubMed ID: 8903281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversies concerning calcium antagonists.
    Lichtlen PR
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):409-12. PubMed ID: 8924053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ongoing clinical outcome studies of calcium antagonists.
    Opie LH
    Blood Press Monit; 1998 Feb; 3(1):59-68. PubMed ID: 10212333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1995: the year of the calcium antagonist controversy.
    Cohen JD
    Curr Opin Nephrol Hypertens; 1996 May; 5(3):214-8. PubMed ID: 8737855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of calcium-channel blockers.
    Massie BM
    Clin Cardiol; 1998 Dec; 21(12 Suppl 2):II12-7. PubMed ID: 9853194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydropyridine calcium channel blockers and cardiovascular outcomes in elderly patients: a population-based study.
    Bucci C; Mamdani MM; Juurlink DN; Tu JV
    Can J Cardiol; 2008 Aug; 24(8):629-32. PubMed ID: 18685743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists during and after myocardial infarction.
    Sleight P
    Drugs; 1996 Feb; 51(2):216-25. PubMed ID: 8808164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are all calcium antagonists alike?].
    Bertel O
    Schweiz Rundsch Med Prax; 1992 Feb; 81(7):164-7. PubMed ID: 1535950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do calcium antagonists cause death, gastrointestinal bleeding, and cancer?
    Kaplan NM
    Am J Cardiol; 1996 Oct; 78(8):932-3. PubMed ID: 8888668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypotensive efficacy and tolerability of combination of dihydropyridine and non-dihydropyridine calcium antagonists in the treatment of patients with arterial hypertension].
    Iskenderov BG; Burmistrova LF; Berenshteĭn NV; Lokhina TV
    Kardiologiia; 2007; 47(11):44-5. PubMed ID: 18260963
    [No Abstract]   [Full Text] [Related]  

  • 18. [Views on the use of calcium channel blockers in the treatment of heart ischemia and hypertension].
    Halawa B
    Pol Merkur Lekarski; 1998 Sep; 5(27):107-10. PubMed ID: 10101470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
    Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
    Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.